2023 June 15, CommBio's CSO Dr. Peter Atadja presents at the 25th Shanghai International Forum on Biotechnology & Pharmaceutical Industry. His talk, titled “Combining Synthetic Biology and Bacteria Gene Delivery Approaches to Target Intestinal Biology for Metabolic and Chronic Disease Therapy”, highlights advances of CommBio Therapeutics and in the industry.
